Literature DB >> 26299491

What Is the Optimal Treatment of Papillary Thyroid Cancer?

Christa L Jillard1, Randall P Scheri1, Julie Ann Sosa2.   

Abstract

Entities:  

Keywords:  Papillary thyroid cancer; Small molecule therapy; Thyroid surgery; Thyroidectomy

Mesh：

Year:  2015        PMID： 26299491     DOI： 10.1016/j.yasu.2015.03.007

Source DB:  PubMed          Journal:  Adv Surg        ISSN： 0065-3411


× No keyword cloud information.
  12 in total

1.  3D-Printed Template-Guided 125I Seed Brachytherapy: A Salvage Approach for Locoregional Refractory Recurrence of Papillary Thyroid Cancer.

Authors:  Zhen Gao; Hongtao Zhang; Lijuan Zhang; Huimin Yu; Xuemin Di; Zeyang Wang; Zezhou Liu; Aixia Sui; Juan Wang; Gaofeng Shi
Journal:  Eur Thyroid J       Date:  2021-10-04

2.  IL-34 is a potential biomarker for the treatment of papillary thyroid cancer.

Authors:  Ping Zhang; Hao Zhang; Wenwu Dong; Zhihong Wang; Yuan Qin; Changhao Wu; Qi Dong
Journal:  J Clin Lab Anal       Date:  2020-06-23       Impact factor: 2.352

3.  Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma.

Authors:  Wei-Quan Liang; Chun-Fa Chen; Shu-Ming Sun; Xiao-Feng Lu; Chun-Yan Peng; Hao-Yu Lin
Journal:  Cancer Manag Res       Date:  2019-03-06       Impact factor: 3.989

Review 4.  Metabolic reprogramming and its clinical application in thyroid cancer.

Authors:  Shi-Shuai Wen; Ting-Ting Zhang; Di-Xin Xue; Wei-Li Wu; Yu-Long Wang; Yu Wang; Qing-Hai Ji; Yong-Xue Zhu; Ning Qu; Rong-Liang Shi
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

5.  Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer.

Authors:  Zhiyang Li; Weixun Lin; Jiehua Zheng; Weida Hong; Juan Zou; Taofeng Zhang; Yexi Chen; Hai Lu
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

6.  Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma.

Authors:  Rujia Qin; Chunyan Li; Xuemin Wang; Zhaoming Zhong; Chuanzheng Sun
Journal:  Cancer Cell Int       Date:  2021-07-15       Impact factor: 5.722

7.  Thyroid Cancer Metabolism: A Review.

Authors:  Kurren S Gill; Patrick Tassone; James Hamilton; Nikolaus Hjelm; Adam Luginbuhl; David Cognetti; Madalina Tuluc; Ubaldo Martinez-Outschoorn; Jennifer M Johnson; Joseph M Curry
Journal:  J Thyroid Disord Ther       Date:  2016-01-14

8.  Image-guided high-dose-rate interstitial brachytherapy - a valuable salvage treatment approach for loco-regional recurrence of papillary thyroid cancer.

Authors:  Ning Wu; Hongfu Zhao; Dongmei Han; Guanghui Cheng; Zhipeng Zhao; Yuxin Ge
Journal:  J Contemp Brachytherapy       Date:  2016-04-07

9.  Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer.

Authors:  Peng Lin; Yi-Nan Guo; Lin Shi; Xiao-Jiao Li; Hong Yang; Yun He; Qing Li; Yi-Wu Dang; Kang-Lai Wei; Gang Chen
Journal:  Aging (Albany NY)       Date:  2019-01-20       Impact factor: 5.682

10.  S100A12 is a promising biomarker in papillary thyroid cancer.

Authors:  Xiaojie Wang; Zhenxiang Sun; Wei Tian; Chenghao Piao; Xiaochen Xie; Jin Zang; Shiqiao Peng; Xiaohui Yu; Yiwei Wang
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.